Delivery Order SPE2DB22D1041-SPE2DB25FTYC0

Award Date 10/28/24
Potential Completion Date 10/29/24
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,500.45 firm-fixed-price delivery order is for the supply of 4,566,353,622 tablets of Methylphenidate ER 18 mg, a prescription medication used in the treatment of Attention Deficit Hyperactivity Disorder (ADHD). The contract has a period of performance through November 7, 2024 and was awarded on November 6,...
This federal contract award, valued at $3,581.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The purpose of this contract is the delivery of 4,566,150,280 units of Methylphenidate ER 18 mg tablets in 100-count...
This federal contract award, valued at $1,173.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,236,639 units of Methylphenidate ER 18 mg tablets, with a performance period through May 14, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,233.15 firm fixed-price delivery order is for the supply of 100 units of Methylphenidate ER 18 mg tablets, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, valued at $3,534.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,239,251 units of methylphenidate 2.5 mg chewable tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a completion date of May 14, 2025 and is a firm fixed-price delivery order, with no set-aside designation....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,504.80 firm-fixed-price delivery order is for the supply of 100 tablets of Methylphenidate ER 54 mg, a medication used to treat ADHD. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,603.12 Firm Fixed Price delivery order contract is for the supply of Methylphenidate ER 18 mg tablets, a medication used to treat ADHD. The contract has an ultimate completion date of February 10, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Methylphenidate ER 27 mg tablets, a generic drug used to treat attention deficit hyperactivity disorder (ADHD). The Firm Fixed Price contract has a ceiling value of $2,199.72 and runs through October 31, 2024. This award is a Delivery Order under an Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,303.90 firm fixed price delivery order is for the supply of 4,566,278,350 tablets of Methylphenidate ER 18 mg, a medication used to treat attention deficit hyperactivity disorder (ADHD). The award has an ultimate completion date of October 31, 2024 and was made on October 30, 2024. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,225.75 firm fixed-price delivery order is for the supply of 4,564,690,721 tablets of Methylphenidate ER 18 mg, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
  • SPE2DB22D1041
    Indefinite Delivery Contract
  • SPE2DB22D1041-SPE2DB25FTYC0
    Delivery Order

This federal contract award, valued at $3,159.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order under the DLA's Indefinite Delivery Contract (IDC), is for the supply of 4,566,248,904 units of Methylphenidate ER 18 mg tablets, a medication used to treat attention deficit hyperactivity disorder (ADHD). The contract has a period of performance through October 29, 2024 and a firm fixed price pricing structure. This award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen's extensive experience in supplying pharmaceutical products and medical supplies to federal healthcare programs, particularly within the military and veterans' healthcare systems, positions the company as a key vendor for the DLA and other government agencies.

Generated 1/27/25, 1:17 PM